首页> 外文期刊>Journal of Materials Chemistry, B. materials for biology and medicine >Polymer cross-linking: a nanogel approach to enhancing the relaxivity of MRI contrast agents
【24h】

Polymer cross-linking: a nanogel approach to enhancing the relaxivity of MRI contrast agents

机译:聚合物交联:增强MRI造影剂松弛性的纳米凝胶方法

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Polymer cross-linking was explored as an approach for increasing the relaxivity of macromolecular contrast agents for magnetic resonance imaging. Poly(ethylene glycol) methyl ether methacrylate, N-(2-aminoethyl) methacrylamide hydrochloride, and the cross-linker ethylene glycol dimethacrylate were copolymerized under free radical conditions. By tuning the cross-linker content and reaction concentration, it was possible to obtain 10 nm nanogels in a single synthetic step. The pendant amine moieties were functionalized with an isothiocyanate derivative of diethylenetriaminepentaacetic acid (DTPA) and Gd(III) was chelated. In comparison with a linear control polymer prepared under the same conditions in the absence of the cross-linking agent, the nanogel contrast agent did exhibit enhanced relaxivity with an r, of 20.8 ± 0.2 at 20 MHz and 17.5 ± 0.4 at 60 MHz (corresponding to the clinical field strength of 1.5 T). The nuclear magnetic resonance dispersion profile was modeled to demonstrate that the enhanced relaxivity was a result of the nanogel agent's increased rotational correlation time, that is proposed to result from the constraint on motion imparted by the cross-linking. T1 weighted imaging in mice showed enhanced contrast and vascular circulation for the nanogel relative to Gd(III)-DTPA (Magnevist) demonstrating the future promise of these new agents.
机译:聚合物交联被探索为增加磁共振成像大分子造影剂弛豫度的一种方法。聚(乙二醇)甲基醚甲基丙烯酸酯,N-(2-氨基乙基)甲基丙烯酰胺盐酸盐和交联剂乙二醇二甲基丙烯酸酯在自由基条件下共聚。通过调整交联剂含量和反应浓度,可以在一个合成步骤中获得10 nm纳米凝胶。用二亚乙基三胺五乙酸(DTPA)的异硫氰酸酯衍生物官能化侧基胺部分,并螯合Gd(III)。与在相同条件下不存在交联剂的情况下制备的线性对照聚合物相比,纳米凝胶造影剂确实显示出增强的弛豫性,r在20 MHz时为20.8±0.2,在60 MHz时为17.5±0.4(对应达到1.5 T的临床磁场强度)。对核磁共振弥散曲线进行建模,以证明增强的弛豫性是纳米凝胶剂旋转相关时间增加的结果,这是由于交联对运动的限制所致。相对于Gd(III)-DTPA(Magnevist),小鼠的T1加权成像显示纳米凝胶的对比度增强和血管循环增强,证明了这些新药物的未来前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号